Carol Karp
General Counsel bei PROTHENA CORPORATION PLC
Vermögen: - $ am 30.04.2024
Profil
Carol D.
Karp is currently the Vice Chairman-Trustees Board at Rochester Christian University and the Chief Regulatory Officer at Prothena Corp.
Plc.
Previously, she held positions such as Officer at VIVUS, Inc., SVP-Regulatory Affairs, Quality & Drug Safety at CV Therapeutics, Inc., Senior VP-Regulatory Affairs & Compliance at Esperion Therapeutics, Inc., Vice President-Scientific Affairs at Powderject Technologies BV, and Vice President & Head-Global Regulatory Affairs at Janssen Alzheimer Immunotherapy.
Ms. Karp obtained her undergraduate degree from Rochester Christian University and New York University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
PROTHENA CORP. PLC
-.--% | 04.03.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Carol Karp
| Unternehmen | Position | Beginn |
|---|---|---|
| PROTHENA CORPORATION PLC | General Counsel | 15.12.2016 |
| Rochester Christian University | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Carol Karp
| Unternehmen | Position | Ende |
|---|---|---|
| ESPERION THERAPEUTICS, INC. | Compliance Officer | 01.01.2014 |
| Janssen Alzheimer Immunotherapy | General Counsel | 01.01.2013 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | General Counsel | 02.05.2011 |
| VIVUS, INC. | Corporate Officer/Principal | - |
| Powderject Technologies BV | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Carol Karp
| Rochester Christian University | Undergraduate Degree |
| New York University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ESPERION THERAPEUTICS, INC. | Health Technology |
| PROTHENA CORPORATION PLC | Health Technology |
| Private Unternehmen | 4 |
|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
| Powderject Technologies BV | |
VIVUS, Inc.
 VIVUS, Inc. Pharmaceuticals: MajorHealth Technology VIVUS, Inc. engaged in the development and commercialization of novel therapeutic products. The firm’s products were indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and it was headquartered in Campbell, CA. | Health Technology |
| Janssen Alzheimer Immunotherapy |
